Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Aishite Pharmaceutical is a pharmaceutical manufacturing company based in Fuzhou, China, specializing in the production of active pharmaceutical ingredients (APIs) and advanced chemical intermediates. As a subsidiary of Jiangxi Synergy Pharmaceutical and part of the Boya Bio-pharmaceutical Group, the company focuses on high-quality chemical synthesis for various therapeutic categories, including cardiovascular and anti-viral treatments. The firm operates large-scale production facilities designed to meet international GMP standards, supporting the supply chain for both its parent group and external partners. Its core business involves the development of efficient synthetic routes for generic drugs and providing contract manufacturing services. The company plays a strategic role in the vertical integration of its parent organization's chemical drug division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Aishite Pharmaceutical.